Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of intravitreal triamcinolone versus laser for diffuse diabetic macular oedema
2005-001385-14Phase 3Completed
- Sponsor
- IOBA
- Start
- Sep 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of triamcinolone acetonide in diabetic macular edema (DME) and diabetic retinopathy (DR) (2 arms), sponsored by IOBA. Primary endpoint: Visual acuity improvement. Started Sep 2005; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
diabetic macular edema (DME)diabetic retinopathy (DR)
Beyond the preview
Go deeper on 2005-001385-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001385-14.